Join Humacyte for a virtual KOL event with a Q&A session, featuring Charles Keith Ozaki, MD (Brigham and Women’s Hospital), Mohamad Anas Hussain, MD, PhD (Brigham and Women’s Hospital), and Timmy Lee, MD, MSPH (University of Alabama at Birmingham), who will discuss the current treatment landscape and unmet need for improved arteriovenous (AV) access in hemodialysis patients.

During the event, the surgeons will share case studies and highlight Phase 3 results for Humacyte’s acellular tissue engineered vessel (ATEV™) product candidate versus arteriovenous fistula (AVF), for hemodialysis access for patients with end-stage kidney disease. The ATEV is an investigational, first-in-class bioengineered human tissue that is designed to be a universally implantable vascular conduit for use in arterial replacement and repair and dialysis access.

A live question and answer session will follow the formal presentations.